Valneva SE ADR
Price & Volume
Stats
See more52W Range | $5.42-$12.25 |
Market Cap | $555M |
Shares Short | 153,342 |
Financials
See moreRevenue (12 Mos) | $174.6M |
Revenue Growth (YoY) | -9.9% |
Gross Profit (12 Mos) | -$17.7M |
Diluted EPS | -$1.59 |
News
See moreYahoo Finance • 6 days ago
Jefferies Reiterates Buy Rating on Valneva (VALN) After Phase 3 Data
Yahoo Finance • 20 days ago
Pfizer Lyme Vaccine Data Adds New Angle To Vaccine Portfolio Story
Yahoo Finance • 21 days ago
Valneva Plunges As Lyme Vaccine Misses Key Goal In Phase 3 Trial; Shows More Than 70% Efficacy
Yahoo Finance • 21 days ago
Traders Digest Signs of Easing Middle East Tensions as US Equity Futures Rise Pre-Bell
About
CEO | Mr. Thomas Lingelbach |
Address | 6 rue Alain Bombard, Saint-Herblain, France, 44800 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 674 |
